Literature DB >> 28374280

Does personal genome testing drive service utilization in an adult preventive medicine clinic?

Ny Hoang1,2, Robin Hayeems3, Jill Davies4, Shuye Pu5, Syed Wasim6, Lea Velsher4, James Aw4, Sébastien Chénier7, Dimitri J Stavropoulos8, Riyana Babul-Hirji6,9, Rosanna Weksberg6,9, Cheryl Shuman6,9.   

Abstract

Personal genome testing (PGT) that assesses risk for common diseases may influence the use of preventive health services, but outcome data are limited. We aimed to assess health service utilization following PGT. We conducted a retrospective matched cohort study at an adult health clinic. Medical records of clients who pursued PGT at their comprehensive health assessment (CHA) over a 1-year period (N = 388) were reviewed and compared to age- and sex-matched clients who underwent CHA but not PGT (N = 388). We measured condition-specific health services used post CHA up to two subsequent visits while accounting for confounding factors (e.g., family history, health status, and age). A relatively equal number of post CHA services were used by clients who pursued PGT and those who did not pursue PGT (52% and 48%, respectively). Overall and across the majority of conditions examined, clients' service utilization was significantly associated with health status, e.g., clients identified as "at risk" on CHA for heart attack used 2.86 times more services than clients not at risk. Pursuing PGT was not significantly associated with increased use of services post CHA overall or for most of the conditions examined. Our data demonstrate that health status rather than pursuing PGT is the strongest driver of service utilization in this population. Overall, pursuit of PGT and PGT results does not appear to significantly drive the utilization of downstream health services.

Entities:  

Keywords:  Clinical utility; Genetic testing; Personal genome testing; Preventive medicine; Service utilization

Year:  2017        PMID: 28374280      PMCID: PMC5496836          DOI: 10.1007/s12687-017-0297-5

Source DB:  PubMed          Journal:  J Community Genet        ISSN: 1868-310X


  16 in total

1.  Limitations of direct-to-consumer advertising for clinical genetic testing.

Authors:  Sarah E Gollust; Sara Chandros Hull; Benjamin S Wilfond
Journal:  JAMA       Date:  2002-10-09       Impact factor: 56.272

Review 2.  Genomics of cardiovascular disease.

Authors:  Christopher J O'Donnell; Elizabeth G Nabel
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

Review 3.  Genomewide association studies and assessment of the risk of disease.

Authors:  Teri A Manolio
Journal:  N Engl J Med       Date:  2010-07-08       Impact factor: 91.245

Review 4.  The behavioral response to personalized genetic information: will genetic risk profiles motivate individuals and families to choose more healthful behaviors?

Authors:  Colleen M McBride; Laura M Koehly; Saskia C Sanderson; Kimberly A Kaphingst
Journal:  Annu Rev Public Health       Date:  2010       Impact factor: 21.981

5.  Effect of direct-to-consumer genomewide profiling to assess disease risk.

Authors:  Cinnamon S Bloss; Nicholas J Schork; Eric J Topol
Journal:  N Engl J Med       Date:  2011-01-12       Impact factor: 91.245

6.  The general public's understanding and perception of direct-to-consumer genetic test results.

Authors:  J W Leighton; K Valverde; B A Bernhardt
Journal:  Public Health Genomics       Date:  2011-06-30       Impact factor: 2.000

7.  Genomic information as a behavioral health intervention: can it work?

Authors:  Cinnamon S Bloss; Lisa Madlensky; Nicholas J Schork; Eric J Topol
Journal:  Per Med       Date:  2011-11       Impact factor: 2.512

Review 8.  Direct-to-consumer personal genome testing and cancer risk prediction.

Authors:  Cecelia A Bellcross; Patricia Z Page; Dana Meaney-Delman
Journal:  Cancer J       Date:  2012 Jul-Aug       Impact factor: 3.360

9.  Patients' understanding of and responses to multiplex genetic susceptibility test results.

Authors:  Kimberly A Kaphingst; Colleen M McBride; Christopher Wade; Sharon Hensley Alford; Robert Reid; Eric Larson; Andreas D Baxevanis; Lawrence C Brody
Journal:  Genet Med       Date:  2012-07       Impact factor: 8.822

10.  Public awareness and use of direct-to-consumer personal genomic tests from four state population-based surveys, and implications for clinical and public health practice.

Authors:  Katherine Kolor; Debra Duquette; Amy Zlot; Joan Foland; Beth Anderson; Rebecca Giles; Jennifer Wrathall; Muin J Khoury
Journal:  Genet Med       Date:  2012-07-19       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.